Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first-quarter 2025 financial results before the stock market opens on Monday, May 5, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 AM Eastern Time.
Speakers on the call will include Stanley M. Bergman, chairman of the board and chief executive officer of Henry Schein, and Ronald N. South, senior vice president and chief financial officer.
Investors can access the call by visiting https://investor.henryschein.com/webcasts.
A replay will be available on the Henry Schein website following the presentation.
Cautionary Note Regarding Forward-Looking Statements
In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations, and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, and achievements—or industry results—to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These statements include EPS and adjusted EBITDA guidance and are generally identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make,” or other comparable terms.
A fuller discussion of our operations, financial condition, and status of litigation matters—including factors that may affect our business and future prospects—is contained in documents we have filed with the United States Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K, and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to:
- Our dependence on third parties for the manufacture and supply of our products
- Our ability to develop or acquire, maintain, and protect new products (particularly technology products) and technologies that achieve market acceptance with acceptable margins
- Transitional challenges associated with acquisitions, dispositions, and joint ventures, including the failure to achieve anticipated synergies/benefits, as well as significant demands on our operations, information systems, legal, regulatory, compliance, financial, and human resources functions
- Certain provisions in our governing documents that may discourage third-party acquisitions
- Adverse changes in supplier rebates or other purchasing incentives
- Risks related to the sale of corporate brand products
- Security risks associated with our information systems and technology products and services, such as cyberattacks or other privacy or data security breaches (including the October 2023 incident)
- Effects of a highly competitive and consolidating market (including competition from third-party online commerce sites)
- Changes in the health care industry
- Risks from expansion of customer purchasing power and multi-tiered costing structures
- Increases in shipping costs or other service issues with third-party shippers
- General global and domestic macroeconomic and political conditions, including inflation, deflation, recession, ongoing wars, fluctuations in energy pricing and currency exchange rates, international trade agreements, potential trade barriers, and terrorism
- Failure to comply with existing and future regulatory requirements
- Risks associated with the EU Medical Device Regulation
- Non-compliance with health care fraud laws or regulations
- Risks related to the collection, storage, and processing of sensitive personal information or electronic health record standards
- Changes in tax legislation
- Product liability, intellectual property, and other legal claims
- Customs policy risks or legislative import restrictions
- Public health crises such as disease outbreaks, pandemics (e.g., COVID-19), and other natural or man-made disasters
- Risks associated with our global operations and litigation matters
- Challenges in hiring and retaining employees and maintaining key relationships
The order in which these factors appear should not be construed to indicate their relative importance or priority.
We caution that these factors may not be exhaustive and that many are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements except as required by law.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.
Our business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering more than 300,000 branded and corporate brand products through its main distribution centers.
A FORTUNE 500 company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The company’s sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 12 percent since Henry Schein became a public company in 1995.
For more information, visit www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.
